Pan Zheng - Publications

Affiliations: 
Yale University, New Haven, CT 

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Muthana MM, Du X, Liu M, Wang X, Wu W, Ai C, Su L, Zheng P, Liu Y. CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment. Elife. 12. PMID 38127423 DOI: 10.7554/eLife.87281  0.33
2023 Muthana MM, Du X, Liu M, Wang X, Wu W, Ai C, Su L, Zheng P, Liu Y. CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment. Biorxiv : the Preprint Server For Biology. PMID 36909522 DOI: 10.1101/2023.03.01.530608  0.33
2019 Liu Y, Zheng P. Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy. Trends in Pharmacological Sciences. PMID 31836191 DOI: 10.1016/j.tips.2019.11.003  0.305
2019 Liu Y, Zheng P. Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy. Trends in Pharmacological Sciences. PMID 31836191 DOI: 10.1016/j.tips.2019.11.003  0.305
2019 Paluskievicz CM, Cao X, Abdi R, Zheng P, Liu Y, Bromberg JS. T Regulatory Cells and Priming the Suppressive Tumor Microenvironment. Frontiers in Immunology. 10: 2453. PMID 31681327 DOI: 10.3389/fimmu.2019.02453  0.305
2019 Paluskievicz CM, Cao X, Abdi R, Zheng P, Liu Y, Bromberg JS. T Regulatory Cells and Priming the Suppressive Tumor Microenvironment. Frontiers in Immunology. 10: 2453. PMID 31681327 DOI: 10.3389/fimmu.2019.02453  0.305
2019 Tao R, Murad N, Xu Z, Zhang P, Okonechnikov K, Kool M, Rivero-Hinojosa S, Lazarski C, Zheng P, Liu Y, Eberhart CG, Rood BR, Packer R, Pei Y. MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research. PMID 30862721 DOI: 10.1158/0008-5472.Can-18-1787  0.304
2019 Tao R, Murad N, Xu Z, Zhang P, Okonechnikov K, Kool M, Rivero-Hinojosa S, Lazarski C, Zheng P, Liu Y, Eberhart CG, Rood BR, Packer R, Pei Y. MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research. PMID 30862721 DOI: 10.1158/0008-5472.Can-18-1787  0.304
2018 Du X, Tang F, Liu M, Su J, Zhang Y, Wu W, Devenport M, Lazarski CA, Zhang P, Wang X, Ye P, Wang C, Hwang E, Zhu T, Xu T, ... Zheng P, et al. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research. PMID 29472691 DOI: 10.1038/s41422-018-0011-0  0.315
2018 Du X, Tang F, Liu M, Su J, Zhang Y, Wu W, Devenport M, Lazarski CA, Zhang P, Wang X, Ye P, Wang C, Hwang E, Zhu T, Xu T, ... Zheng P, et al. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research. PMID 29472691 DOI: 10.1038/s41422-018-0011-0  0.315
2018 Du X, Liu M, Su J, Zhang P, Tang F, Ye P, Devenport M, Wang X, Zhang Y, Liu Y, Zheng P. Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice. Cell Research. PMID 29463898 DOI: 10.1038/s41422-018-0012-z  0.349
2018 Du X, Liu M, Su J, Zhang P, Tang F, Ye P, Devenport M, Wang X, Zhang Y, Liu Y, Zheng P. Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice. Cell Research. PMID 29463898 DOI: 10.1038/s41422-018-0012-z  0.349
2018 Zheng P, Zhang Y, Ye P, Wu W, Chen C, Liu Y. Cd24 Defects Recapitulates Features of Aging Hematopoiesis Biology of Blood and Marrow Transplantation. 24: S477-S478. DOI: 10.1016/j.bbmt.2017.12.573  0.311
2017 Tang F, Zhang P, Ye P, Lazarski CA, Wu Q, Bergin IL, Bender TP, Hall MN, Cui Y, Zhang L, Jiang T, Liu Y, Zheng P. A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice. Elife. 6. PMID 29206103 DOI: 10.7554/Elife.32497  0.319
2017 Tang F, Zhang P, Ye P, Lazarski CA, Wu Q, Bergin IL, Bender TP, Hall MN, Cui Y, Zhang L, Jiang T, Liu Y, Zheng P. A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice. Elife. 6. PMID 29206103 DOI: 10.7554/Elife.32497  0.319
2017 Toubai T, Rossi C, Oravecz-Wilson K, Zajac C, Liu C, Braun T, Fujiwara H, Wu J, Sun Y, Brabbs S, Tamaki H, Magenau J, Zheng P, Liu Y, Reddy P. Siglec-G represses DAMP-mediated effects on T cells. Jci Insight. 2. PMID 28724800 DOI: 10.1172/jci.insight.92293  0.326
2016 Li CS, Tang F, Zhang P, Jiang T, Saunders TL, Zheng P, Liu Y. Trap1a is an X-linked and cell-intrinsic regulator of thymocyte development. Cellular & Molecular Immunology. PMID 27063468 DOI: 10.1038/cmi.2015.108  0.383
2016 Li CS, Tang F, Zhang P, Jiang T, Saunders TL, Zheng P, Liu Y. Trap1a is an X-linked and cell-intrinsic regulator of thymocyte development. Cellular & Molecular Immunology. PMID 27063468 DOI: 10.1038/cmi.2015.108  0.383
2015 Ye P, Liu Y, Chen C, Tang F, Wu Q, Wang X, Liu CG, Liu X, Liu R, Liu Y, Zheng P. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Molecular Cell. 57: 708-20. PMID 25639470 DOI: 10.1016/j.molcel.2014.12.034  0.475
2015 Ye P, Liu Y, Chen C, Tang F, Wu Q, Wang X, Liu CG, Liu X, Liu R, Liu Y, Zheng P. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Molecular Cell. 57: 708-20. PMID 25639470 DOI: 10.1016/j.molcel.2014.12.034  0.475
2015 Wong C, Chen C, Wu Q, Liu Y, Zheng P. A critical role for the regulated wnt-myc pathway in naive T cell survival. Journal of Immunology (Baltimore, Md. : 1950). 194: 158-67. PMID 25429066 DOI: 10.4049/jimmunol.1401238  0.547
2015 Wong C, Chen C, Wu Q, Liu Y, Zheng P. A critical role for the regulated wnt-myc pathway in naive T cell survival. Journal of Immunology (Baltimore, Md. : 1950). 194: 158-67. PMID 25429066 DOI: 10.4049/jimmunol.1401238  0.547
2014 Wang Y, Liu Y, Tang F, Bernot KM, Schore R, Marcucci G, Caligiuri MA, Zheng P, Liu Y. Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells. Blood. 124: 1127-35. PMID 24994068 DOI: 10.1182/Blood-2013-12-544221  0.311
2014 Wang Y, Liu Y, Tang F, Bernot KM, Schore R, Marcucci G, Caligiuri MA, Zheng P, Liu Y. Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells. Blood. 124: 1127-35. PMID 24994068 DOI: 10.1182/Blood-2013-12-544221  0.311
2014 Thaxton JE, Liu B, Zheng P, Liu Y, Li Z. Deletion of CD24 impairs development of heat shock protein gp96-driven autoimmune disease through expansion of myeloid-derived suppressor cells. Journal of Immunology (Baltimore, Md. : 1950). 192: 5679-86. PMID 24808359 DOI: 10.4049/jimmunol.1302755  0.336
2014 Thaxton JE, Liu B, Zheng P, Liu Y, Li Z. Deletion of CD24 impairs development of heat shock protein gp96-driven autoimmune disease through expansion of myeloid-derived suppressor cells. Journal of Immunology (Baltimore, Md. : 1950). 192: 5679-86. PMID 24808359 DOI: 10.4049/jimmunol.1302755  0.336
2012 Tang F, Wu Q, Ikenoue T, Guan KL, Liu Y, Zheng P. A critical role for Rictor in T lymphopoiesis. Journal of Immunology (Baltimore, Md. : 1950). 189: 1850-7. PMID 22815285 DOI: 10.4049/Jimmunol.1201057  0.32
2012 Chen G, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai X, Liu J, Woodiga SA, Chen C, ... ... Zheng P, et al. Erratum: Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction Nature Biotechnology. 30: 193-193. DOI: 10.1038/Nbt0212-193B  0.335
2011 Wu Q, Liu Y, Chen C, Ikenoue T, Qiao Y, Li CS, Li W, Guan KL, Liu Y, Zheng P. The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 1106-12. PMID 21709159 DOI: 10.4049/Jimmunol.1003968  0.526
2011 Wu Q, Liu Y, Chen C, Ikenoue T, Qiao Y, Li CS, Li W, Guan KL, Liu Y, Zheng P. The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 1106-12. PMID 21709159 DOI: 10.4049/Jimmunol.1003968  0.526
2011 Chen GY, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai XF, Liu JQ, Woodiga SA, Chen C, ... ... Zheng P, et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nature Biotechnology. 29: 428-35. PMID 21478876 DOI: 10.1038/Nbt.1846  0.492
2011 Chen GY, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai XF, Liu JQ, Woodiga SA, Chen C, ... ... Zheng P, et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nature Biotechnology. 29: 428-35. PMID 21478876 DOI: 10.1038/Nbt.1846  0.492
2010 Li CS, Chen C, Zheng P, Liu Y. Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis. Plos One. 5: e13439. PMID 20976169 DOI: 10.1371/Journal.Pone.0013439  0.521
2010 Li CS, Chen C, Zheng P, Liu Y. Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis. Plos One. 5: e13439. PMID 20976169 DOI: 10.1371/Journal.Pone.0013439  0.521
2010 Chen C, Liu Y, Liu Y, Zheng P. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. The Journal of Clinical Investigation. 120: 4091-101. PMID 20972332 DOI: 10.1172/JCI43873  0.506
2010 Chen C, Liu Y, Liu Y, Zheng P. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. The Journal of Clinical Investigation. 120: 4091-101. PMID 20972332 DOI: 10.1172/JCI43873  0.506
2009 Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Science Signaling. 2: ra75. PMID 19934433 DOI: 10.1126/scisignal.2000559  0.507
2009 Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Science Signaling. 2: ra75. PMID 19934433 DOI: 10.1126/scisignal.2000559  0.507
2009 Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 16: 336-46. PMID 19800578 DOI: 10.1016/J.Ccr.2009.08.016  0.439
2009 Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 16: 336-46. PMID 19800578 DOI: 10.1016/J.Ccr.2009.08.016  0.439
2009 Liu R, Wang L, Chen G, Katoh H, Chen C, Liu Y, Zheng P. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Research. 69: 2252-9. PMID 19276356 DOI: 10.1158/0008-5472.CAN-08-3717  0.477
2009 Liu R, Wang L, Chen G, Katoh H, Chen C, Liu Y, Zheng P. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Research. 69: 2252-9. PMID 19276356 DOI: 10.1158/0008-5472.CAN-08-3717  0.477
2009 Chen C, Liu Y, Liu Y, Zheng P. The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle (Georgetown, Tex.). 8: 1158-60. PMID 19270502 DOI: 10.4161/cc.8.8.8139  0.493
2009 Chen C, Liu Y, Liu Y, Zheng P. The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle (Georgetown, Tex.). 8: 1158-60. PMID 19270502 DOI: 10.4161/cc.8.8.8139  0.493
2008 Liu R, Wang L, Chen C, Liu Y, Zhou P, Wang Y, Wang X, Turnbull J, Minassian BA, Liu Y, Zheng P. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms. Molecular and Cellular Biology. 28: 7236-44. PMID 18824542 DOI: 10.1128/Mcb.01334-08  0.476
2008 Liu R, Wang L, Chen C, Liu Y, Zhou P, Wang Y, Wang X, Turnbull J, Minassian BA, Liu Y, Zheng P. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms. Molecular and Cellular Biology. 28: 7236-44. PMID 18824542 DOI: 10.1128/Mcb.01334-08  0.476
2008 Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. The Journal of Experimental Medicine. 205: 2397-408. PMID 18809716 DOI: 10.1084/Jem.20081297  0.508
2008 Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. The Journal of Experimental Medicine. 205: 2397-408. PMID 18809716 DOI: 10.1084/Jem.20081297  0.508
2008 Chen GY, Chen C, Wang L, Chang X, Zheng P, Liu Y. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 5163-6. PMID 18390696 DOI: 10.4049/jimmunol.180.8.5163  0.542
2008 Chen GY, Chen C, Wang L, Chang X, Zheng P, Liu Y. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 5163-6. PMID 18390696 DOI: 10.4049/jimmunol.180.8.5163  0.542
2008 Chen C, Liu Y, Liu R, Ikenoue T, Guan K, Liu Y, Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species The Journal of Cell Biology. 183: i1-i1. DOI: 10.1083/JCB1831OIA1  0.361
Show low-probability matches.